We're now hiring a postdoc in biostatistics & cancer genetics at @DanaFarber
Data Science! Prediction models for germline pathogenic variants (new NIH R01) + collaborative research in cancer genetics.
Rolling review. Details & how to apply: https://t.co/9zkPgD1aHT
Regression models for average hazard
Hajime Uno, Lu Tian, Miki Horiguchi, Satoshi Hattori, Kenneth L Kehl
Biometrics, Volume 80, Issue 2, June 2024, ujae037, https://t.co/Nh7rHtE7VQ
Published: 21 May 2024
Welcome to our new #JCOPO Editorial Fellows! Drs. @MitchElliott18, Miki Horiguchi & @ferguskeane2 will spend the next year getting a peek behind the curtain of JCO PO and learning from Drs. James Ford, Ying Lu, Bryan Schneider, and others on what it's like to be a journal editor!
Excited to have our new paper on epub'ed in @AGA_Gastro today looking at familial burden of specific #LynchSyndrome cancers and carriers' own likelihood of having such cancers. #SelfPromotion Study led by @LeahBillerMD and Miki Horguchi @DanaFarber https://t.co/VLhXzO8y7E
Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults https://t.co/vHhNvx7jxB
Study finds new evidence of health threat from chemicals in marijuana and tobacco smoke - Dana-Farber Cancer Institute | Boston, MA https://t.co/UKEMEHuem9
Very glad to see the difference in RMST was used as the primary analysis. "Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM" https://t.co/Q9LgwzwXiT
Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm<sub>5</sub> Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing https://t.co/7DS0yGJA3V
Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology - Miki Horiguchi, Michael J Hassett, Hajime Uno, 2020 https://t.co/1rXiACtDDb